AGENUS INC Logo

AGENUS INC

A clinical-stage biotechnology company specializing in immuno-oncology therapies.

AGEN | US

Overview

Corporate Details

ISIN(s):
US00847G8042
LEI:
Country:
United States of America
Address:
3 FORBES ROAD, 2421 LEXINGTON

Description

Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 17:05
4
English ZIP 7.7 KB
2025-12-01 17:05
4
English ZIP 7.7 KB
2025-11-17 17:05
4
English ZIP 7.7 KB
2025-11-10 18:12
10-Q
English ZIP 2.0 MB
2025-11-10 08:32
8-K
English ZIP 284.3 KB
2025-11-05 17:05
4
English ZIP 7.7 KB
2025-10-30 15:24 English ZIP 8.1 KB
2025-10-21 18:05
4
English ZIP 7.7 KB
2025-10-09 18:05
8-K
English ZIP 52.2 KB
2025-10-06 18:05
4
English ZIP 7.7 KB
2025-10-03 18:05
4
English ZIP 6.8 KB
2025-10-03 18:05
4
English ZIP 7.3 KB
2025-09-23 19:12
8-K
English ZIP 49.6 KB
2025-09-23 18:05
4
English ZIP 7.7 KB
2025-09-09 18:05
4
English ZIP 7.7 KB

Automate Your Workflow. Get a real-time feed of all AGENUS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AGENUS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AGENUS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA
Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.